Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07114692Not yet recruiting
Randomised, open-label trial of adipose stromal vascular components + extracellular matrix gel in dermal atrophy (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Dermal thickness at 8 weeks. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07114692.